-
11.
公开(公告)号:ZA9809313B
公开(公告)日:2000-04-13
申请号:ZA9809313
申请日:1998-10-13
Applicant: BASF AG
Inventor: PUHL MICHAEL , AMBERG WILHELM , HILLEN HEINZ , KLING ANDREAS , HERGENROEDER STEFAN , MARKERT CLAUS OTTO
IPC: A61K38/00 , A61P1/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/08 , A61P13/12 , A61P25/06 , A61P35/00 , A61P43/00 , C07K1/06 , C07K5/065 , C07K5/078 , C07K , A61K
CPC classification number: C07K5/06139 , A61K38/00 , C07K5/06078
-
公开(公告)号:AU9626498A
公开(公告)日:1999-05-03
申请号:AU9626498
申请日:1998-09-18
Applicant: BASF AG
Inventor: PUHL MICHAEL , AMBERG WILHELM , HILLEN HEINZ , KLING ANDREAS , HERGENRODER STEFAN , MARKERT CLAUS OTTO
-
公开(公告)号:AU1023599A
公开(公告)日:1999-05-03
申请号:AU1023599
申请日:1998-09-18
Applicant: BASF AG
Inventor: PUHL MICHAEL , ZECHEL JOHANN-CHRISTIAN , DITRICH KLAUS , HILLEN HEINZ , KOHL TANJA , ERHARDT MELANIE , HERGENRODER STEFAN , MARKERT CLAUS OTTO
IPC: C07D333/40 , A61K31/198 , A61K31/27 , A61K31/381 , A61K31/4704 , A61K31/498 , A61P1/04 , A61P1/18 , A61P7/02 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P25/06 , A61P35/00 , C07C271/12 , C07C271/20 , C07C323/56 , C07D215/48 , C07D241/44 , C07D333/38 , C07D333/16 , C07D241/42 , C07C271/22 , C07D215/14 , A61K31/38 , A61K31/47 , A61K31/495
Abstract: Pharmaceutically active compounds are prepared as described and used to produce pharmaceutical preparations for treating diseases.
-
公开(公告)号:CA2305499A1
公开(公告)日:1999-04-22
申请号:CA2305499
申请日:1998-09-18
Applicant: BASF AG
Inventor: ERHARDT MELANIE , PUHL MICHAEL , KOHL TANJA , HERGENRODER STEFAN , HILLEN HEINZ , ZECHEL JOHANN-CHRISTIAN , MARKERT CLAUS OTTO , DITRICH KLAUS
IPC: C07D333/40 , A61K31/198 , A61K31/27 , A61K31/381 , A61K31/4704 , A61K31/498 , A61P1/04 , A61P1/18 , A61P7/02 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P25/06 , A61P35/00 , C07C271/12 , C07C271/20 , C07C323/56 , C07D215/48 , C07D241/44 , C07D333/38 , C07D333/16 , C07D215/14 , C07C271/22 , A61K31/38 , C07D241/42 , A61K31/47 , A61K31/495
Abstract: Novel pharmaceutically active compounds of general formula (I), their preparation and use for producing pharmaceutical compositions for the treatment of diseases are disclosed. (Endothelin conversion enzyme inhibitors (=ECE)).
-
-
-